MCKAYLA POLLARD: Open Payments
NPI 1952995763 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,152 in 93 payments from 25 companies in 2025. Trend: 2023 $1,230 · 2024 $1,961 · 2025 $2,152
Food & beverage: $2,055Education: $98
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $304 |
| Amgen Inc. | 9 | $293 |
| PFIZER INC. | 21 | $258 |
| ABBVIE INC. | 9 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $154 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $112 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Madrigal Pharmaceuticals | 3 | $94 |
| Astellas Pharma US Inc | 2 | $90 |
Products named: EVENITY, AIRSUPRA, ELIQUIS, Kerendia, UPTRAVI, QULIPTA, CAPLYTA, PREVNAR 20.
Industry payments across OR — which companies pay providers there.
